Your email has been successfully added to our mailing list.

×
0 0 0 -0.00358708648864095 -0.00936339323363421 -0.0541297705073331 -0.068137314363942 -0.0226257935201391
Stock impact report

Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses [Yahoo! Finance]

Immunovant, Inc. (IMVT) 
Company Research Source: Yahoo! Finance
other autoimmune candidate IMVT-1402 inches closer to a pivotal trial later this year. The results for batoclimab include “strong response rates” following an injection with the therapy, according to the US immunology specialist's CEO Pete Salzmann. Meanwhile, Immunovant has set its sights on a pivotal trial for IMVT-1402 after an investigational new drug application (IND) was cleared by the US Food and Drug Administration. The biopharma expects to initiate the study, which will also involve Graves' disease patients, by the end of this year. Immunovant has been investigating batoclimab – a monoclonal antibody – in a Phase IIa trial (NCT05907668) with Graves' disease patients who were hyperthyroid despite antithyroid therapy. Graves' disease is an autoimmune condition that leads to an overactive thyroid gland, resulting in elevated levels of two main thyroid hormones called triiodothyronine and thyroxine, also known as T3 and T4. Antithyroid drugs (ATDs) are the treatment of ch Show less Read more
Impact Snapshot
Event Time:
IMVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IMVT alerts
Opt-in for
IMVT alerts

from News Quantified
Opt-in for
IMVT alerts

from News Quantified